Evidence map›Paper›PMID 37205936›Full record

ArticleHealth science reports2023

COVID-19 vaccination success in Bangladesh: Key strategies were prompt response, early drives for vaccines, and effective awareness campaigns.

Nazmunnahar, Bulbul Ahamed, Md Anamul Haque, Md Tanbir, A S M Roknuzzaman, Rapty Sarker, Md Rabiul Islam

Abstract readCase Reports
In one paragraph

Article in Health science reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

NazmunnaharDepartment of Sociology, Eden Women's College National University Bangladesh Gazipur Bangladesh.
Bulbul AhamedDepartment of Pharmacy University of Asia Pacific Dhaka Bangladesh.
Md Anamul HaqueDepartment of Pharmacy University of Asia Pacific Dhaka Bangladesh.
Md TanbirDepartment of Pharmacy University of Asia Pacific Dhaka Bangladesh.
A S M RoknuzzamanDepartment of Pharmacy University of Asia Pacific Dhaka Bangladesh.
Rapty SarkerDepartment of Pharmacy University of Asia Pacific Dhaka Bangladesh.
Md Rabiul IslamDepartment of Pharmacy University of Asia Pacific Dhaka Bangladesh.ORCID 0000-0003-2820-3144

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bangladesh is located in Southeast Asia that has a high population density. It is a lower-middle-income country. The COVID-19 pandemic severely impacted the nation that slowed its economic growth. It halted major industries, crippling the nation's economy. The students were uncertain after the declaration of school closures. Hospitals could not treat other patients properly due to the vast health burden of COVID-19. Bangladesh put up a solid fight during COVID-19 as a lower-middle-income country. Prompt action, early vaccination drives, effective awareness campaigns, and widespread public involvement have enabled Bangladesh to bring more than 90% of its population into COVID-19 vaccination coverage. It was possible by the effective diplomatic and local health strategy implemented by the Bangladeshi government, the country's extensive prior experience, and its long history of achieving a high success rate in other vaccination campaigns. Bangladesh was able to flatten the curve sooner than other developed countries. Therefore, the cogs of everyday social life and the economy begin to turn once more. The strategy Bangladesh used to combat the COVID-19 pandemic through vaccination and diplomatic policy by calling on its prior experience has the potential to serve as a model for other low- and middle-income countries and an example for developed nations.

Indexed as

awarenessBangladeshCOVID‐19COVID‐19 vaccinesimmunization programsvaccination

Identifiers

PMID37205936
PMCPMC10190122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.